TAKEDA PHARMACEUTICAL CO LTD's Net Worth
$461 Million
Who is TAKEDA PHARMACEUTICAL CO LTD?
TAKEDA PHARMACEUTICAL CO LTD has an estimated net worth of $461 Million. This is based on reported shares across multiple companies, which include Calithera Biosciences, Inc., Xilio Therapeutics, Inc., Theseus Pharmaceuticals, Inc., Day One Biopharmaceuticals, Inc., Translate Bio, Inc., Ovid Therapeutics Inc., BiomX Inc., Phathom Pharmaceuticals, Inc., Mirum Pharmaceuticals, Inc., Cortexyme, Inc., Molecular Templates, Inc., HilleVax, Inc., and Myovant Sciences Ltd..
SEC CIK
TAKEDA PHARMACEUTICAL CO LTD's CIK is 0001395064
Past Insider Trading and Trends
2022 was TAKEDA PHARMACEUTICAL CO LTD's most active year for acquiring shares with 5 total transactions. TAKEDA PHARMACEUTICAL CO LTD's most active month to acquire stocks was the month of June. 2021 was TAKEDA PHARMACEUTICAL CO LTD's most active year for disposing of shares, totalling 58 transactions. TAKEDA PHARMACEUTICAL CO LTD's most active month to dispose stocks was the month of April. 2018 saw TAKEDA PHARMACEUTICAL CO LTD paying a total of $138,543,068.75 for 7,420,625 shares, this is the most they've acquired in one year. In 2020 TAKEDA PHARMACEUTICAL CO LTD cashed out on 7,078,945 shares for a total of $146,169,557.13, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Calithera Biosciences, Inc. (CALA) Snapshot price: $0.03
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.48M |
—
|
—
| 1.48M |
Oct 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Theseus Pharmaceuticals, Inc. (THRX) Snapshot price: $4.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.62M |
—
|
—
| 1.62M |
Oct 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $15.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.63% | -297.27K |
$18.49 | -$5,496,869.49 | 6.12M |
Dec 7 - Dec 8
| |||
Form 4
| -1.69% | -110.21K |
$18.10 | -$1,994,529.59 | 6.42M |
Dec 3 - Dec 6
| |||
Form 4
| +0.88% | 57.22K |
—
|
—
| 6.53M |
Nov 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Translate Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.82M |
$20.68 | -$141,140,834.56 |
0
|
Jun 30
| |||
Form 4
| -0.58% | -40.09K |
$19.75 | -$791,698.50 | 6.82M |
Jun 3
| |||
Form 4
| -3.02% | -213.87K |
$19.81 | -$4,237,024.07 | 6.87M |
Jun 1 - Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||